Analystreport

BIOLASE, Inc. (NASDAQ: BIOL) had its "buy" rating re-affirmed by analysts at Colliers Securities.

Biolase, Inc.  (BIOL) 
Last biolase, inc. earnings: 3/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: biolase.com/investors